Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retapamulin for Reducing MRSA Nasal Carriage

NCT01461668 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT01461668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01461668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retapamulin for Reducing MRSA Nasal Carriage
Lead sponsor
University of California, Irvine
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2012
Completion date
December 31, 2017
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methicillin-resistant staphylococcus aureus